Literature DB >> 24376097

Growth hormone treatment of patients with Fanconi anemia after hematopoietic cell transplantation.

Gregory P Forlenza1, Lynda E Polgreen, Bradley S Miller, Margaret L MacMillan, John E Wagner, Anna Petryk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24376097      PMCID： PMC3989390          DOI： 10.1002/pbc.24910

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  9 in total

1.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Endocrine studies in Fanconi's anaemia. Report of 4 cases.

Authors:  A Aynsley-Green; M Zachmann; E A Werder; R Illig; A Prader
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

3.  Fanconi's anaemia in the genetics of neoplasia.

Authors:  M Swift
Journal:  Nature       Date:  1971-04-09       Impact factor: 49.962

4.  Endocrine phenotype of children and adults with Fanconi anemia.

Authors:  Susan R Rose; Kasiani C Myers; Meilan M Rutter; Robin Mueller; Jane C Khoury; Parinda A Mehta; Richard E Harris; Stella M Davies
Journal:  Pediatr Blood Cancer       Date:  2012-01-31       Impact factor: 3.167

5.  Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.

Authors:  S Dupuis-Girod; E Gluckman; J C Souberbielle; R Brauner
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

6.  Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry.

Authors:  M P Wajnrajch; J M Gertner; Z Huma; J Popovic; K Lin; P C Verlander; S D Batish; P F Giampietro; J G Davis; M I New; A D Auerbach
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

Review 7.  Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.

Authors:  A D Auerbach; R G Allen
Journal:  Cancer Genet Cytogenet       Date:  1991-01

8.  Endocrine abnormalities in patients with Fanconi anemia.

Authors:  Neelam Giri; Dalia L Batista; Blanche P Alter; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2007-04-10       Impact factor: 5.958

9.  Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study.

Authors:  A Butturini; R P Gale; P C Verlander; B Adler-Brecher; A P Gillio; A D Auerbach
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113
  9 in total
  7 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

Review 2.  Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.

Authors:  Christen L Ebens; Margaret L MacMillan; John E Wagner
Journal:  Expert Rev Hematol       Date:  2016-12-21       Impact factor: 2.929

3.  Bone mineral density in children with fanconi anemia after hematopoietic cell transplantation.

Authors:  Anna Petryk; Lynda E Polgreen; Jessie L Barnum; Lei Zhang; James S Hodges; K Scott Baker; John E Wagner; Julia Steinberger; Margaret L MacMillan
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-13       Impact factor: 5.742

Review 4.  Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

Authors:  Anna Petryk; Roopa Kanakatti Shankar; Neelam Giri; Anthony N Hollenberg; Meilan M Rutter; Brandon Nathan; Maya Lodish; Blanche P Alter; Constantine A Stratakis; Susan R Rose
Journal:  J Clin Endocrinol Metab       Date:  2015-01-09       Impact factor: 5.958

5.  A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.

Authors:  Jonathan Metts; Brittany Harrington; Emad Salman; Scott M Bradfield; Jennifer Flanary; Maua Mosha; Ernest Amankwah; Stacie Stapleton
Journal:  Childs Nerv Syst       Date:  2022-03-08       Impact factor: 1.475

Review 6.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.

Authors:  Jasmine D Peake; Eishi Noguchi
Journal:  Hum Genet       Date:  2022-05-21       Impact factor: 5.881

7.  Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.

Authors:  Jessie L Barnum; Anna Petryk; Lei Zhang; Todd E DeFor; K Scott Baker; Julia Steinberger; Brandon Nathan; John E Wagner; Margaret L MacMillan
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-12       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.